Renal Cancer - Results from #3160

Mass Spectrometry Imaging enables Discrimination of Renal Oncocytoma from Renal Cell Cancer Subtypes and Normal Kidney Tissues. December 23, 2019

Role of metabolomics-derived biomarkers to identify renal cell carcinoma: a comprehensive perspective of the past ten years and advancements. December 23, 2019

Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience. December 20, 2019

LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches. December 20, 2019

Concomitant radiotherapy and transarterial chemoembolization reduce skeletal-related events related to bone metastases from renal cell carcinoma. December 20, 2019

Surgical quality, cancer control and functional preservation: introducing a novel Trifecta for robot-assisted partial nephrectomy. December 19, 2019

Perioperative Detection of Circulating Tumor Cells in Radical or Partial Nephrectomy for Renal Cell Carcinoma. December 19, 2019

MicroRNA-Mediated Metabolic Reprograming in Renal Cancer. December 19, 2019

Statin use and the risk of renal cell carcinoma: national cohort study. December 18, 2019

Upregulated expression of eIF3C is associated with malignant behavior in renal cell carcinoma. December 18, 2019

Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma. December 18, 2019

Recurrence risk groups after nephrectomy for renal cell carcinoma. December 17, 2019

COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma. December 17, 2019

The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma. December 17, 2019

Drug resistance in papillary RCC: from putative mechanisms to clinical practicalities. December 16, 2019

The Effect of Weight Change During Treatment With Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma. December 16, 2019

First-Line Systemic Therapy for Metastatic Clear-Cell Renal Cell Carcinoma: Critical Appraisal of Emerging Options. December 16, 2019

Metabolic syndrome is associated with improved cancer-specific survival in patients with localized clear cell renal cell carcinoma. December 13, 2019

Prognostic value of immune-related genes in clear cell renal cell carcinoma. December 13, 2019

D-loop Mutations in Renal Cell Carcinoma Improve Predictive Accuracy for Cancer-Related Death by Integrating with Mutations in the NADH Dehydrogenase Subunit 1 Gene. December 13, 2019

Page 159 of 459